A new form of imaging – PET combined with MRI – shows promise for several types of cancer, according to researchers from University Hospitals (UH) Case Medical Center, Ohio. As detailed in an article published in September 2013, this novel hybrid imaging modality can enhance the diagnosis, staging and treatment planning of these conditions.
PET/MRI brings together the capabilities of PET and MRI, allowing technicians to better visualise both functional and anatomical information. By superimposing one scan on the other, the technology makes it possible to view a single combined digital image and more precisely pinpoint any areas of abnormality.
In collaboration with Philips Healthcare, the team examined 145 cancer patients. They concluded that PET/MRI was useful for colorectal, cervical, uterine, ovarian and pancreatic cancers, and provided scope to improve patient care. It improved their diagnostic confidence, and provided accurate information about cancer metastasis and disease staging.
"Our preliminary experience with this new diagnostic imaging technology proves that it has potential for use in oncologic applications," said lead author Dr Karin Herrman.
